Host stress and immune responses during aerosol challenge of Brown Norway rats with Yersinia pestis by Susan T. Gater et al.
ORIGINAL RESEARCH ARTICLE
published: 30 November 2012
doi: 10.3389/fcimb.2012.00147
Host stress and immune responses during aerosol
challenge of Brown Norway rats with Yersinia pestis
Susan T. Gater1†, Kristen N. Peters1,2†, Andrew G. Kocsis1,2, Miqdad O. Dhariwala1,2,3,
Deborah M. Anderson1,2 and Paul E. Anderson1,2*
1 Laboratory for Infectious Disease Research, University of Missouri, Columbia, MO, USA
2 Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA
3 Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA
Edited by:
Chad J. Roy, Tulane University, USA
Reviewed by:
Jose A. Bengoechea, Fundacion
Caubet-CIMERA Illes Balears, Spain
Philip Stewart, Rocky Mountain
Laboratories/NIAID/NIH, USA
*Correspondence:
Paul E. Anderson, Laboratory for
Infectious Disease Research,
University of Missouri, 1817 East
Campus Loop, Columbia, MO
65211, USA.
e-mail: andersonpaul@missouri.edu
†These authors equally contributed
to this work.
Inhalation exposure models are becoming the preferred method for the comparative study
of respiratory infectious diseases due to their resemblance to the natural route of infection.
To enable precise delivery of pathogen to the lower respiratory tract in a manner that
imposes minimal biosafety risk, nose-only exposure systems have been developed. Early
inhalation exposure technology for infectious disease research grew out of technology
used in asthma research where predominantly the Collison nebulizer is used to generate
an aerosol by beating a liquid sample against glass. Although infectious aerosol droplets
of 1–5μm in size can be generated, the Collison often causes loss of viability. In this work,
we evaluate a gentler method for aerosolization of living cells and describe the use of the
Sparging Liquid Aerosol Generator (SLAG) in a rat pneumonic plague model. The SLAG
creates aerosols by continuous dripping of liquid sample on a porous metal disc. We show
the generation of 0.5–1μm Yersinia pestis aerosol particles using the SLAG with spray
factors typically ranging from 10−7 to 10−8 with no detectable loss of bacterial viability.
Delivery of these infectious particles via nose-only exposure led to the rapid development
of lethal pneumonic plague. Further, we evaluated the effect of restraint-stress imposed
by the nose-only exposure chamber on early inflammatory responses and bacterial
deposition. Elevated serum corticosterone which peaked at 2 h post-procedure indicated
the animals experienced stress as a result of restraint in the nose-only chamber.
However, we observed no correlation between elevated corticosterone and the amount
of bacterial deposition or inflammation in the lungs. Together these data demonstrate
the utility of the SLAG and the nose-only chamber for aerosol challenge of rodents by
Y. pestis.
Keywords: Yersinia pestis, pneumonic plague, aerosol, Brown Norway rat, infectious disease, stress,
corticosterone
INTRODUCTION
Inhalation exposure is the best way to model infection of the
lower respiratory tract which can have a high fatality rate due
to limited immune defense mechanisms (Eisele and Anderson,
2011). In humans, infectious aerosols are created by coughing
and sneezing, allowing for the generation of force sufficient to
dislodge particles from infected lungs. In the laboratory, model-
ing of respiratory infections using inhalation exposure technol-
ogy has favored the use of the Collison nebulizer as a method
for aerosolization in the laboratory, originally developed for
asthma research (May, 1973). The Collison generates aerosols
by forcibly beating liquid culture against glass generating infec-
tious aerosol particles of around 1μm in diameter (Thomas
et al., 2009). Exposure chambers involving unrestrained whole-
animal or heavily restrained nose-only challenges are becoming
widely used in combination with the Collison nebulizer to deliver
a defined and highly reproducible amount of infectious agent.
Unfortunately, some bacterial agents such as Yersinia pestis and
Pseudomonas aeruginosa, are sensitive to aerosolization through
the Collison nebulizer resulting in the death of 50% or more of
the bacterial population (Welkos et al., 2002; Agar et al., 2009).
Moreover, even for those pathogens that are less sensitive to the
shear forces generated by the Collison, there are likely changes in
bacterial gene expression that may otherwise not occur during a
natural infection. In fact, virulence gene expression changes due
to the stress of liquid shear have been documented, which in turn
may impact disease or immunity (Castro et al., 2011). Further,
respiratory pathogens such as Y. pestis infect humans and impose
a significant biosafety risk to the experimental model which can
be of particular concern with whole animal exposure chambers.
In order to prevent unknown effects on the infection and to
better mimic the natural infection, we explored the use of an alter-
native nebulizer based on Sparging Liquid Aerosol Generation
(SLAG) wherein aerosols are generated by bubbling compressed
air through a bacterial suspension onto a metal frit (Mainelis
et al., 2005; Simon et al., 2011). In this work, we describe the use of
the SLAG for the nose-only inhalation exposure of BrownNorway
rats to Y. pestis, the causative agent of pneumonic plague.
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Pneumonic plague is a rapidly progressing and contagious
respiratory infection that leads to death in humans and most
mammals within days of infection (Pollitzer, 1954). The bac-
teria overwhelm the innate immune system of the host due to
their rapid growth, evasion of phagocytosis, and induction of
necrotic death of inflammatory cells (Bergsbaken and Cookson,
2009). The infection is established following an initial active
suppression of the immune response that presumably allows
the organism to gain the upper hand (Lathem et al., 2005).
A number of virulence factors, including the type III secre-
tion system and secreted proteases are involved in establishing
this condition. Vaccines targeting the type III secretion system
have been found efficacious in animal models of plague and are
under evaluation for use in humans (Rosenzweig et al., 2011b).
Because of their similar response to Y. pestis infection, rats have
been used as a surrogate to evaluate vaccines and therapeu-
tics against plague (Anderson et al., 2009; Rosenzweig et al.,
2011a). Whole-animal and nose-only aerosol exposure have been
developed for mice, rats, and non-human primates for evalu-
ation of vaccines and therapeutics against pneumonic plague
(Davis et al., 1996; Agar et al., 2009; Rosenzweig et al., 2011a;
Fellows et al., 2012). Though these systems offer many similarities
to the natural infection, animal restraint is generally necessary,
especially in nose-only systems where precise delivery to the res-
piratory tract can occur while minimizing contamination of the
animal fur.
Mammals, including rats, respond to stress by the rapid pro-
duction of corticosteroids. Animal restraint causes an elevation
in serum corticosterone that peaks 2 h post-restraint and can
be affected by many factors including time of day and method
of blood collection (Fagin et al., 1983; Paskittia et al., 2000;
Moldow et al., 2005; Vahl et al., 2005; Abatan et al., 2008).
Moreover, both anti- and pro-inflammatory responses to stress
have been reported (Robert and Kupper, 1999; Soderholm et al.,
2002; Vicario et al., 2010). Whether this also occurs as a localized
inflammatory response during an inhalation exposure procedure
is unknown. An increase in stress in animals under restraint
during nose-only inhalation exposure might therefore lead to
non-specific inflammatory responses that could influence the
developing infection thereby making data generated in these
animal models subject to misinterpretation.
In this work, we use the SLAG nebulizer to model pneu-
monic plague and address the role of restraint-stress in the Brown
Norway rat during the early stage of infection. We found that
most, but not all, of the animals experienced elevated corticos-
terone as a result of their restraint in the nose-only chamber.
Repeated restraint in the chamber did not prevent an increase
in corticosterone and there remained a similar percentage of ani-
mals that showed no evidence of stress. We monitored bacterial
deposition and Ly6G+ cell populations during the early stage
of infection and found no correlation between these inflamma-
tory cells and elevated corticosterone levels in the serum and
lethal pneumonic plague developed within 72 h. Together, our
data demonstrate the utility of the SLAG nebulizer in pneu-
monic plague models and show that in spite of a temporary stress
response, the nose-only challenge did not detectably alter the
progression of plague.
MATERIALS ANDMETHODS
BACTERIAL STRAINS
Y. pestis CO92, a clinical isolate of the Orientalis biovar, was rou-
tinely grown fresh from frozen stocks and streaked for isolation
onto heart infusion agar (HIA) plates containing 0.005% Congo
Red and 0.2% galactose to identify bacteria that retained the pig-
mentation locus (Surgalla and Beesley, 1969; Welkos et al., 1997).
For pneumonic plague challenge, 6 flasks of 50ml HIB supple-
mented with 2.5mMCaCl2 were each inoculated with a single red
pigmented colony and grown for 24 h at 37◦C, 120 rpm. Bacteria
were collected by centrifugation, washed once, and re-suspended
in sterile PBS and pooled and the OD600 was measured. As nec-
essary, bacteria were diluted in sterile PBS to achieve a desired
OD600. All handling of samples containing live Y. pestis CO92
was performed in a select agent authorized biosafety level 3 lab-
oratory under protocols approved by the University of Missouri
Institutional Biosafety Committee.
AEROSOL GENERATION
The nose-only inhalation exposure chamber is diagrammed in
Figure 1. Aerosols were created using a SLAG (CH Technologies,
Westwood, NJ) fitted with a 1′′ diameter, 1mm thick porous
stainless steel disc (frit) with 0.5μm pore size unless otherwise
indicated (Mott Corporation; Farmington, CT). The sample was
recirculated throughout the exposure via a peristaltic pump deliv-
ering 1mL/min. Air flow through the SLAG was delivered at 10
standard liters per minute (SLPM) and dilution air was added at
the volume required to deliver approximately 10 times the esti-
mated respiratory minute volume (MV) per rat times the total
number of nose-only ports on the apparatus (Guyton, 1947).
Air flow on all supply, exhaust, and sample lines was controlled
using individual mass flow controllers (Alicat Scientific, Inc.,
Tucson, AZ).
Aerosol particle characterization was performed via a Welas
Digital 2000 white light spectrometer particle sizer (Palas;
Karlsruhe, Germany). 0.5 SLPM was sampled directly from an
animal port. Bacterial viability and concentration in the aerosol
were tested by plating serial dilutions of samples collected at
5 SLPM in two all-teflon impingers (SKC, Inc.; Eighty Four, PA),
containing 10mL HIB and 20μL Emulsion B antifoam (Sigma;
St. Louis, MO), via a manifold below the exposure tower.
Aerosol concentration (CAero) for a determined impinger sam-
ple concentration (CImp), impinger sample volume (V), sampling
flow rate (QImp), and time (t) was calculated in CFU/mL as fol-
lows: CAero = CImp × V/QImp × t. The spray factor is the ratio
between the starting concentration of the sample (CNeb) and the
CAero as such: Spray factor = CAero/CNeb. The presented dose
is the potential aerosolized dose that might be inhaled by any
subject, calculated as CAero× MV × t.
ANIMALS
These studies were carried out in strict accordance with the rec-
ommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health and were approved
by the Animal Care and Use Committee of the University of
Missouri. All efforts were made to minimize suffering of the
animals.
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FIGURE 1 | Nose-only inhalation exposure equipment schematic.
Arrows show direction of supply air and vacuum applied to the exposure
tower. Bacterial suspension is drawn from the nebulizer jar via peristaltic
pump and allowed to drip on a frit where air is forced through the
accumulated film. Excess suspension settles back to the bottom of the
jar and is continuously drawn up. Sampling impingers are placed above
the point where sample mixes with dilution air, but below the exposure
tower.
Male and female Brown Norway rats (150–250 g), were pur-
chased from Charles River Laboratories (Wilmington, MA) or
were bred and raised in barrier facilities at the University of
Missouri. During pneumonic plague challenge, rats were main-
tained in select agent approved biosafety level 3 containment
facilities at the University of Missouri. Animals were challenged
using a nose-only exposure system consisting of one or two 12-
port layers (CH Technologies; Westwood, NJ) within a Class III
biological safety cabinet (Germfree; Ormond Beach, FL). Supply
air to the nebulizer and dilution lines was supplied by a Jun Air
air compressor while exhaust and sampling lines were attached to
a vacuum pump (Gast Mfg.; Benton Harbor, MI) housed within
the cabinet. The Class III cabinet was maintained at a negative
pressure of approximately −1′′ wc relative to the laboratory and
the exposure tower wasmaintained at−0.4 to−0.6′′ wc relative to
the class III cabinet; all pressures were monitored by magnehelic
gauges.
For challenges, rats were restrained in nose-only expo-
sure tubes and placed on the inhalation exposure tower (CH
Technologies, Westwood, NJ). Animals were allowed to accli-
mate to the exposure environment and allowed to breathe clean,
dry air for 10min before being exposed to infectious aerosol
for 20min. Animals were then exposed to clean, dry air for
an additional 10min and returned to housing. All infected rats
were monitored regularly by assignment of health scores. Animals
were euthanized by CO2 asphyxiation followed by bilateral
pneumothorax, methods approved by the American Veterinary
Medical Association Guidelines on Euthanasia. Following infec-
tion, animals were either euthanized at the times indicated
or observed for up to 14 days for clinical signs of acute
disease.
ENUMERATION OF BACTERIAL LOAD
Following euthanasia, nasal washes were collected by perfusing
sterile PBS into the trachea and extruding through the nasal cav-
ity. Lungs and trachea were aseptically removed, separated, and
homogenized in sterile PBS, followed by serial dilution and plat-
ing in triplicate on HIA or Yersinia selective agar for enumeration
(Sarovich et al., 2010). Plates were incubated for 48–72 h at 26◦C.
SERUM ANALYSIS
Prior to challenge, blood was collected from the saphenous vein;
post-challenge blood was collected following euthanasia by car-
diac puncture. Samples were centrifuged to remove cells. Serum
samples were frozen at –80◦C and analyzed after testing for the
presence of live bacteria. Samples that contained bacteria were
sterilized by passage through a 0.22μm filter prior to analysis.
For serum analysis of corticosterone levels following handling
and exposure to PBS, blood was collected from naïve rats from
the saphenous vein a week prior to mock exposure to PBS aerosol.
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Post-mock exposure to PBS aerosol, the same rats were bled from
the saphenous vein and serum was analyzed for corticosterone by
Enzyme Immuno Assay (EIA) as described below.
QUANTIFICATION OF IL-6 BY ELISA
Bronchoalveolar lavage fluid was collected from rats by flushing
the infected lungs with 5ml of sterile PBS. Samples were frozen
at −80◦C and analyzed after testing for the presence of live bac-
teria. Samples that contained bacteria were sterilized by passage
through a 0.22μm filter prior to analysis. Samples were ana-
lyzed for IL-6 by ELISA-Max Deluxe (Biolegend, San Diego, CA)
according to the manufacturer’s directions.
QUANTIFICATION OF CORTICOSTERONE BY EIA
Serum samples were analyzed for the presence of corticosterone
using the Corticosterone EIA (Immunodiagnostic Systems,
Scottsdale, AZ) according to the manufacturer’s directions.
QUANTIFICATION OF BLOOD GLUCOSE
Serum samples were analyzed for the presence of glucose using
the Glucose Assay Kit (Cayman Chemical Company, Ann Arbor,
MI) according to the manufacturer’s directions.
FLOW CYTOMETRY ANALYSES OF INFLAMMATION
The inferior lobe of the lungs was removed and injected with
2mg/ml collagenase-dispase (Roche, Indianapolis, IN), homog-
enized in 2mg/ml collagenase-dispase followed by incubation
at 37◦C, 150 rpm for 45min. Following incubation, lung sam-
ples were filtered through a 40 micron filter and red blood cells
were lysed with 1× ACK lysis solution. Samples were stained
with mouse anti-rat Ly6G-FITC (Abcam, Cambridge, MA) and
washed with FACS buffer (1× PBS with 1% FBS). Samples were
run on a MoFlo XDP (Beckman Coulter, Brea, CA) and analyzed
using FlowJo software (Tree Star, Inc., Ashland, OR).
STATISTICAL ANALYSIS
Data from all replicates were analyzed for statistical signifi-
cance by One-Way ANOVA using GraphPad Prism (GraphPad
Software, La Jolla, CA).
RESULTS
DEVELOPMENT OF AEROSOLIZATION PROTOCOL FOR Y. pestis
Y. pestis CO92 was placed in the SLAG nebulizer at different con-
centrations and aerosolized and collected in impingers containing
sterile HIB media. Bacterial concentration in the nebulizer and
impingers were determined and the spray factor was calculated.
These results showed that spray factor was variable, with higher
spray factors typically seen at the lower bacterial concentration
and lower spray factors typically observed at the higher bacterial
concentrations (Figure 2A). We also measured deposition of bac-
teria in the upper respiratory tract of the Brown Norway rat of
particles generated with different frit sizes (0.5, 1.0, or 2.0μm).
These results demonstrated occasional deposition of bacteria in
the trachea but not upper respiratory tract on the 0.5μm frit
while the 1.0 and 2.0μm frits produced particles that occasionally
were found in the nasal passage (Figure 2B). We therefore used
the 0.5μm frit for the remaining experiments.
FIGURE 2 | SLAG nebulizer generates highly infectious Yersinia pestis
aerosol. (A) Spray factor is plotted compared to nebulizer concentration for
exposure of 8 animals in a single slice chamber. (B) Nasal wash and trachea
were plated to enumerate bacterial deposition; dotted line indicates limit of
detection; n = 4 per group, collected in single trial. (C) Average particle
sizes over the course of three 20min challenges at low (Cneb = 1.1× 108
CFU), medium (Cneb = 3.9× 108 CFU) and high (Cneb = 1.4× 109 CFU)
concentrations were monitored via white light spectroscopy; challenges
were performed in a double slice exposure system. All challenge
parameters other than nebulizer concentration remained constant during
data collection. (D) Groups of 8 male or female rats were challenged by
inhalation exposure to the indicated doses of Y. pestis CO92 and were
monitored for 14 days for survival (data shown was combined from 2
independent trials).
We challenged male and female Brown Norway rats with
increasing doses of Y. pestisCO92 delivered by the SLAG nebulizer
on a 0.5μm frit. Aerosol particle size was measured for each dose
and found to vary slightly according to the concentration of bac-
teria in the nebulizer. Overall, the majority of particles found at a
low dose (Cneb = 2.5 × 108 CFU) were 0.5μmwhile the majority
particle size was 0.7μm at a 25-fold higher dose (Figure 2C). The
range of particles was 0.3–1.1μm, and overall, these aerosol par-
ticles are of the size that would be predicted to be inhaled into
the lower respiratory tract (Thomas et al., 2009). The bacteria
were highly infectious and rapidly lethal when aerosolized by the
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SLAG nebulizer, and>50% of animals succumbed to challenge at
72 h post-infection with some animals in each group developing
lethal disease in only 60 h (Figure 2D). A presented dose of only
1 × 103 CFU led to 75% lethality while 2 × 106 CFU presented
dose caused 100% lethality. These data are comparable to previ-
ous reports in the Brown Norway rat using a Collison nebulizer
and Madison chamber to model pneumonic plague (Agar et al.,
2009).
NOSE-ONLY EXPOSURE CHAMBER LEADS TO ELEVATED STRESS IN
THE BROWN NORWAY RAT
Placement in the nose-only exposure chamber requires signifi-
cant restraint to optimize inhalation of the bioaerosol through
the nares. Since it is widely appreciated that animal restraint
causes stress that can be monitored as elevated corticosterone
in the serum, we used this measurement to understand how
the rats responded to the exposure chamber. We conducted a
series of studies to determine deposition of bacteria in the lower
respiratory tract while monitoring levels of corticosterone and
glucose in the serum. Groups of 8–16 male Brown Norway rats
were challenged by inhalation exposure to 5 × 105 CFU Y. pestis
CO92 (presented dose). Animals were euthanized 6, 24, 48, or
72 h later and blood collected by cardiac puncture. Serum was
collected and processed for glucose and corticosterone. Both glu-
cose and corticosterone levels seemed to vary, with a large range
of responses (Figures 3A,B). Despite some variations in both
corticosterone and glucose levels, differences between all time
points were not statistically significant. At the 24 h time point,
bronchial lavage fluid was collected and assayed for the pres-
ence of the pro-inflammatory cytokine IL-6, whichmight indicate
activation of an NF-κB inflammatory response. These results
showed little to no IL-6 at 24 h post-exposure (Figure 3C). Since
Y. pestis is known to suppress inflammation in the early stage
of infection, this result suggests that the pathogenesis of infec-
tion progresses normally in this model. At the 6 h time point,
lungs were homogenized in sterile PBS and plated for bacterial
enumeration to determine the efficiency of deposition in the
lower respiratory tract. Similar to the stress measurements at early
time points, inhalation of Y. pestis into the lower respiratory tract
was variable, ranging from undetectable to 3 × 104 CFU/lung
(Figure 3D).
We monitored the effect of acclimatization on corticosterone
in a group of 18 male Brown Norway rats (>225 g). In this exper-
iment, animals were monitored for baseline corticosterone and
placed in the exposure chamber for a mock challenge 3 days later.
Blood was drawn immediately after removal from the exposure
chamber and animals were returned to housing. After another 3
days, animals were once again placed in the chamber and blood
drawn immediately after. Animals were then challenged with a
presented dose of 5 × 105 CFU and bacterial deposition in the
lung was determined at 6 h post-challenge. Elevated corticos-
terone was observed upon restraint, whether it was the first or
second time the animals had been placed in the exposure cham-
ber, and in fact, if anything, the average corticosterone value
increased upon the second restraint (Figure 4A). Six hours after
exposure, lung deposition was determined and found to range
from 5 × 101 to 2 × 104 CFU, a range of deposition from 0.1 to
4% (Figure 4B). No correlation between levels of corticosterone
in the serum and deposition of bacteria in the lung was observed
(R2 = 0.002, Figure 4C).
RATS EXPERIENCE EARLY NEUTROPHIL INFILTRATION FOLLOWING
AEROSOL EXPOSURE
We next tested for recruitment of inflammatory cells to the
lung during the first 6 h post-infection to determine whether the
restraint-related increase in corticosterone might correlate with a
change in inflammation. We monitored baseline corticosterone
3 days prior to nose-only aerosol challenge with 5 × 105 CFU
Y. pestis CO92. Animals were euthanized every hour for 6 h post-
challenge. Serum was collected and lung homogenate was ana-
lyzed by flow cytometry for neutrophil recruitment. The inferior
lung lobe was homogenized and stained with anti-Ly6G, which is
FIGURE 3 | Bacterial deposition, stress, and pro-inflammatory responses
during Y. pestis aerosol infection in Brown Norway rats. Male Brown
Norway rats (>225g) were challenged by inhalation exposure with 5 × 105
CFU Y. pestis CO92. Serum corticosterone (A) and glucose (B) were
measured 6, 48, and 72h post-infection (HPI); (C) Bronchoalveolar lavage was
collected at 24 HPI and analyzed for IL-6 by ELISA; (D) Bacterial titer in lung
homogenate was determined at 6 HPI. For (C) and (D), bar indicates the
median value; in (D), the dotted line indicates the limit of detection. Data
shown were collected in one (24 and 72 HPI) or two (6 HPI) independent
experiments; n = total number of animals studied.
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FIGURE 4 | Elevated serum corticosterone in Brown Norway rats
following restraint in nose-only inhalation exposure system does not
impact bacterial deposition in the lower respiratory tract. (A) Male
Brown Norway rats were bled from saphenous vein and analyzed for
corticosterone on day 0, and following 60min mock aerosol challenge on day
7 (PBS1) and day 10 (PBS2); mean value is shown, n = 18, ∗p < 0.05. (B) On
day 13, the same animals were exposed to Y. pestis CO92 aerosol (presented
dose 5 × 105 CFU) and bacterial titer in the lungs was determined at 6 h post
infection (HPI); bar indicates median titer; dotted line indicates limit of
detection. (C) Correlation analysis for serum corticosterone levels and
bacterial titer in the lung at 6 HPI. Data shown was collected in a single trial,
n = 18.
a cell surface marker on neutrophils and eosinophils.We observed
Ly6G+-staining cell populations in both naïve and challenged
animals, ranging from less than 1 to greater than 40% and there
were no detectable differences at any time point (Figures 5A–E).
We also measured corticosterone in the serum of these animals
and observed an increase in the stress hormone at 2 HPI in
all animals in the group, consistent with restraint-related stress
responses (Figure 5F). We compared neutrophil recruitment and
corticosterone levels in each individual animal, combining all
time points, and found no correlation but this may be due to the
low power of the study (R2 = 0.1181, Figure 5G). Taken together,
the data suggest that restraint-related stress caused by the nose-
only exposure chamber does not alter the response to respiratory
infection by Y. pestis.
DISCUSSION
New vaccines and therapeutics that target uncommon infec-
tious diseases may be subjected to the US Food and Drug
Administration’s Animal Rule to obtain licensure. Under this
rule, efficacy data in well-characterized animal models may sub-
stitute for human efficacy data. In this work, we described an
inhalation exposure model of pneumonic plague in the Brown
Norway rat and provide additional support that this animal
model meets the criteria outlined in the guidance for the Animal
Rule (US Department of Health and Human Services Food and
Drug Administration, 2009). Aerosolization is the only method
that recapitulates natural exposure to respiratory pathogens.
Here, we provide a novel method for aerosolizing Y. pestis and
show the integration of maximum biocontainment with minimal
unwanted effects on the experimental model.
Respiratory infections are transmitted by aerosol droplets con-
taining bacterial or viral pathogens. Particles of 1μm have been
reported to be capable of escaping the ciliary action of the trachea
and depositing with high efficiency into the lower respiratory
tract while particles exceeding 3–5μm can be trapped in the nasal
cavity and/or trachea (Roy et al., 2003; Thomas et al., 2008). In
this work, we used the SLAGwith frits of increasing diameter pore
size to generate aerosols of Y. pestis CO92 and deliver through
a nose-only exposure system to Brown Norway rats. With this
method, we found that pore sizes of 0.5–2.0μm in most cases
generated aerosols with particle sizes of 0.3–2.0μm, which would
likely lead to deposition in the lower respiratory tract.
We observed high virulence of Y. pestis CO92 following aerosol
infection, with no detectable loss of bacterial viability. A pre-
sented dose as low as 1 × 103 CFU caused 75% lethality. Similar
nebulizer doses presented to Brown Norway rats through the
whole-animal exposure Madison Chamber resulted in similar
lethality. Importantly, at all doses, at least 50% of animals suc-
cumbed to disease within 60–72 h, some progressing so rapidly
that overt signs of disease were not observed. These data indi-
cate that the Brown Norway rat rapidly succumbs to pneumonic
plague following aerosol challenge.
Nose-only aerosol exposure is ideal for experimental models
of respiratory infections with high morbidity and/or mortal-
ity rates. Our exposure chamber takes advantage of maximum
containment offered by the negative pressure system and its coor-
dination within a class III biosafety cabinet. This allows the use of
animalmodels with potentially high resemblance to natural expo-
sure, improving the utility of data generated in these comparative
models of infectious disease and immunity. Unfortunately, these
highly sophisticated and precise instruments involve the intro-
duction of a potential experimental variable: animal restraint.
Indeed, our evidence suggests that animals are experiencing ele-
vated stress as a result of the restraint imposed by the exposure
chamber. Further, we found that repeated placement of the ani-
mals in the exposure chamber did not readily reduce their stress.
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FIGURE 5 | No correlation between inflammation in the lungs and
elevated serum corticosterone following nose-only exposure of Brown
Norway rats to Y. pestis. Eighteen Male Brown Norway rats (>225g)
were infected by aerosol challenge with 5 × 105 CFU presented dose of
Y. pestis CO92. Lungs (A–E) and blood (F) were harvested at the indicated
time points. Lung homogenates were stained for Ly6G+-FITC followed by
flow cytometric analysis (A–C) Representative histograms for 1 HPI, 4 HPI,
and 6 HPI; (D) Mean percentage Ly6G+ staining cells for 1–6 HPI;
(E) Representative histograms from each time point show the variation of
Ly6G+ cells in the lung. Data shown are representative of two independent
experiments (n = 6 total per group). (F) Mean serum corticosterone levels
from naïve rats (7 days prior to exposure, white bars) and at each time
point (gray bars). Data shown is from one replicate, n = 3 per group.
(G) Correlation of percent Ly6G+ cells and concentration of corticosterone
in the serum at each time point, R2 = 0.1181. Statistical analysis by
One-Way ANOVA with Tukey post-test.
Though we did not analyze the effect of even more acclimi-
tization to the exposure chamber, we presume that eventually,
the animals would acclimate to these conditions. Nevertheless,
we found no detectable differences to the progression of the
infection imposed by those animals experiencing stress responses
indicating extensive acclimatization to the chamber may not
be a necessary practice, at least for pneumonic plague mod-
els. This may be due to the unique pathogenesis of Y. pestis,
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which establishes an immune-suppressive environment upon
pulmonary infection.
SLAGmay generally be preferable to the Collison nebulizer for
the aerosolization of infectious agents. Previously, the Collison
nebulizer has been shown to generate 1–2μm particles that are
effectively inhaled by rodents in a nose-only exposure cham-
ber. The Collison works by capillary action, rapidly accelerating
pathogen into a fast moving stream of air with limited ability
to adjust air flow rates. Aerosols are created when droplets are
formed as the stream impacts the side of the nebulizer jar. In
contrast, with the SLAG, different frit pore sizes allow the fine-
tuning of particle size. The SLAG allows independent adjustments
of air and liquid flow rates. Furthermore, the SLAG can be con-
figured to slowly re-circulate the liquid culture, in contrast to
the Collison, allowing a more efficient use of culture such that
lower volumes can be used. Finally, the SLAG maintains via-
bility of bacteria whereas, for some bacteria, viability has been
shown to decrease by more than 50% during aerosol generation
by the Collison nebulizer. Not only is the viability of some infec-
tious agents affected by the forcible treatment in the Collison,
but it is likely that surviving cells undergoing this treatment may
experience changes in gene expression that could impact viru-
lence. Given the importance that animal models recapitulate the
natural infection as much as possible, and the ability to use nose-
only exposure chambers with animals that are not anesthetized,
these models offer powerful tools for the assessment of efficacy of
vaccines and therapeutics against human infection.
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